Poultry Vaccine Market: By Vaccine (Inactivated Vaccines, Live Attenuated Vaccines, and Others), By Application (Marek’s Disease, Newcastle Disease, Infectious Bursal Disease, Infectious Bronchitis, Avian Influenza, Coccidiosis, Mycoplasma, and Others), and Geography  

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The poultry vaccine market is anticipated to be valued at USD 2199.8 million in 2021 and is expanded to grow at a significant CAGR of 5.8% over 2022-2028. The disease outbreaks in poultry drive the poultry vaccine market. Growing farmed poultry can speed up the spread of infectious pathogens among birds, such as the avian influenza virus, which has the great promise to cause widespread mortality and significant economic losses in poultry. However, poultry is accepted as a good source of protein. The poultry industry will be forced to intensify production in many countries, leading to more significant numbers of farms that house birds at elevated densities. Hence the regulatory bodies are accelerating the approval process for various vaccines related to veterinary health. Increasing awareness among veterinary practitioners about animal vaccination, growing meat consumption, and rising government initiatives for food safety is boosting the market. For instance, in April 2019, according to the Middle East Rating Agency, the Qatar government established central food laboratories with different procedures and analyses on food safety to ensure consumers are provided with contamination-free, safe, and high-quality meat products. The growing poultry population, combined with the rising prevalence of avian diseases, will also drive market growth in the coming years. Moreover, infected meat consumption risks human health, thereby making it imperative that the birds be vaccinated before usage. The main obstacles poultry farms face are the rapid spread of diseases and the lack of treatment options. To prevent such situations, vaccination becomes mandatory. In 2021, the attenuated live vaccines segment held the largest revenue share. Live attenuated vaccines' duration of immunity lasts longer and protects against avian diseases such as infectious bronchitis, infectious bursal disease, and Newcastle disease. Moreover, growing R&D activities, particularly in this field of vaccination, to curb various outbreaks of the diseases mentioned above are accentuating the segment growth.

Recent Market Developments:

In February 2021, Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders. In July 2020, Boehringer Ingelheim acquires GST to strengthen its stem cell capabilities in Animal Health.

Poultry Vaccines Market Summary

Study Period

2022 2028

Base Year

2021

CAGR

5.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Poultry Vaccines Market Dynamics

Across many parts of the world, the poultry industry is expanding and becoming more industrialized. Increased population, increased purchasing power, and urbanization have all been significant growth drivers. Furthermore, growing consumption of meat globally, initiatives are taken by the government, and increasing demand for poultry-related food products are the major factors driving the market's growth. Increasing use of antibiotics and illegal use of vaccines & backyard poultry will hamper the global industry.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Poultry Vaccines Market Segmentation

vaccine type
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Others
By Application
  • Marek’s Disease
  • Newcastle Disease
  • Infectious Bursal Disease
  • Infectious Bronchitis
  • Avian Influenza
  • Coccidiosis
  • Mycoplasma
  • Others
Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA
LOCATION

Geography

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive Summary 2. Global Poultry Vaccines Market Introduction
      2.1. Global Poultry Vaccines Market – Taxonomy
      2.2. Global Poultry Vaccines Market –Definitions
            2.2.1. Vaccine Type
            2.2.2. Application 3. Global Poultry Vaccines Market Dynamics
      3.1. Drivers
      3.2. Restraints
      3.3. Opportunities/Unmet Needs of the Market
      3.4. Trends
      3.5. Global Poultry Vaccines Market Dynamic Factors - Impact Analysis
      3.6. Global Poultry Vaccines Market – Regulations
            3.6.1. U.S.
            3.6.2. Europe 4. Global Poultry Vaccines Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
      4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
      4.3. Market Opportunity Analysis 5. Global Poultry Vaccines Market Analysis, By Vaccine Type, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      5.1. Inactivated Vaccines
            5.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.1.3. Market Opportunity Analysis
      5.2. Live Attenuated Vaccines
            5.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.2.3. Market Opportunity Analysis
      5.3. Recombinant Vaccines
            5.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.3.3. Market Opportunity Analysis 6. Global Poultry Vaccines Market Analysis, By Application, 2015 - 2019 and Forecast, 2020 – 2026
      6.1. Marek’s Disease
            6.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.1.3. Market Opportunity Analysis
      6.2. Newcastle Disease
            6.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.2.3. Market Opportunity Analysis
      6.3. Infectious Bursal Disease
            6.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.3.3. Market Opportunity Analysis
      6.4. Infectious Bronchitis
            6.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.4.3. Market Opportunity Analysis
      6.5. Others
            6.5.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.5.3. Market Opportunity Analysis 7. Global Poultry Vaccines Market Analysis, By Formulation, 2015 - 2019 and Forecast, 2020 – 2026
      7.1. Dry Form (Duct) Vaccines
            7.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.1.3. Market Opportunity Analysis
      7.2. Liquid Vaccines
            7.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.2.3. Market Opportunity Analysis
      7.3. Freeze Dried Vaccines
            7.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.3.3. Market Opportunity Analysis 8. Global Poultry Vaccines Market Analysis, By Region, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      8.1. North America
            8.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.1.3. Market Opportunity Analysis
      8.2. Europe
            8.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.2.3. Market Opportunity Analysis
      8.3. Asia-Pacific
            8.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.3.3. Market Opportunity Analysis
      8.4. Latin America
            8.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.4.3. Market Opportunity Analysis
      8.5. Middle East and Africa
            8.5.1. Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.5.3. Market Opportunity Analysis
      8.6. Global Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Region, 2020 – 2026 9. North America Poultry Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      9.1. Vaccine Type Analysis 2015 - 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            9.1.1. Inactivated Vaccines
            9.1.2. Live Attenuated Vaccines
            9.1.3. Recombinant Vaccines
      9.2. Application Analysis 2015 - 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.2.1. Marek’s Disease
            9.2.2. Newcastle Disease
            9.2.3. Infectious Bursal Disease
            9.2.4. Infectious Bronchitis
            9.2.5. Others
      9.3. Formulation Analysis 2015 - 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.3.1. Dry Form (Duct) Vaccines
            9.3.2. Liquid Vaccines
            9.3.3. Freeze Dried Vaccines
      9.4. Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            9.4.1. U.S.
            9.4.2. Canada
      9.5. North America Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2020 – 2026
      9.6. North America Poultry Vaccines Market Dynamics – Trends 10. Europe Poultry Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      10.1. Country Analysis 2015 - 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            10.1.1. Germany
            10.1.2. UK
            10.1.3. France
            10.1.4. Spain
            10.1.5. Italy
            10.1.6. Russia
            10.1.7. Poland
            10.1.8. Rest of Europe
      10.2. Europe Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2020 – 2026
      10.3. Europe Poultry Vaccines Market Dynamics – Trends 11. Asia-Pacific Poultry Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      11.1. Country Analysis 2015 - 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            11.1.1. Japan
            11.1.2. China
            11.1.3. India
            11.1.4. ASEAN
            11.1.5. Australia & New Zealand
            11.1.6. Rest of Asia-Pacific
      11.2. Asia-Pacific Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2020 – 2026
      11.3. Asia-Pacific Poultry Vaccines Market Dynamics – Trends 12. Latin America Poultry Vaccines Market Analysis, 2012 - 2012 - 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      12.1. Country Analysis 2015 - 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            12.1.1. Brazil
            12.1.2. Mexico
            12.1.3. Argentina
            12.1.4. Venezuela
            12.1.5. Rest of Latin America
      12.2. Latin America Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2020 – 2026
      12.3. Latin America Poultry Vaccines Market Dynamics – Trends 13. Middle East and Africa Poultry Vaccines Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      13.1. Country Analysis 2015 - 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            13.1.1. Gulf Cooperation Council (GCC) Countries
            13.1.2. Israel
            13.1.3. South Africa
            13.1.4. Rest of MEA
      13.2. MEA Poultry Vaccines Market - Opportunity Analysis Index, By Vaccine Type, By Application, By Formulation, and Country, 2020 – 2026
      13.3. MEA Poultry Vaccines Market Dynamics – Trends 14. Competition Landscape
      14.1. Strategic Dashboard of Top Market Players
      14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
            14.2.1. Zoetis (Pfizer, Inc.) (U.S.)
            14.2.2. Merck & Co. Inc. (U.S)
            14.2.3. Boehringer Ingelheim Vetmedica (Germany)
            14.2.4. Elanco (U.S.)
            14.2.5. Bayer Animal Health (Germany)
            14.2.6. Ceva Sante Animale (France)
            14.2.7. Indovax Pvt. Ltd. (India)
            14.2.8. Hester Biosciences Limited. (India)
            14.2.9. Zydus AHL (India) 15. Research Methodology 16. Key Assumptions and Acronyms
  • Merck & Co., Inc.,
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Biovac
  • Zoetis
  • Hester Biosciences Limited
  • KM Biologics
  • Phibro Animal Health Corporation